4//SEC Filing
Dahan Michel 4
Accession 0001562180-24-001994
CIK 0001517022other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 6:02 PM ET
Size
5.0 KB
Accession
0001562180-24-001994
Insider Transaction Report
Form 4
Dahan Michel
SVP, Chief Business Officer
Transactions
- Sale
Common Stock
2024-02-27$1.52/sh−10,744$16,331→ 715,593 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001669737
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 6:02 PM ET
- Size
- 5.0 KB